#News

Flash BioSolutions LAUNCHES GMP PRODUCTION OF REVOLUTIONARY mrna technology for next-generation vaccines and therapies  Toulouse, Occitanie, France, 26 September 2024 […]

Flash BioSolutions increases Gene Delivery RUO production capacity in France to meet surging demand for C2 and C3 GMO-Level Viral Particles   Toulouse, […]

Flash BioSolutions welcomes Stewart Craig to its esteemed Scientific Advisory Board We are thrilled to announce the newest addition to […]

Collaboration between CEA and FLASH Biosolutions for the development of cutaneous cell therapy Flash Therapeutics celebrates a decade of collaboration […]

Flash BioSolutions appoints Anne DEFLISQUE Business & Marketing Director to boost growth We are thrilled to announce the newest addition […]

KiraGen Bio and Flash BioSolutions Announce Innovative Partnership to Revolutionize CAR-T Therapies for Solid Tumors KiraGen Bio and Flash BioSolutions […]

Introducing Flash BioSolutions : Spearheading advancements in Biopharmaceutical CDMO sector Flash BioSolutions® strengthens its position in the Contract Development and […]

Flash BioSolutions obtains Pharmaceutical Establishment status, opening up new avenues for its revolutionary FlashRNA® technology The company’s recent achievement highlights […]

Rebranding : LentiFlash® becomes FlashRNA® Announcement : Our unique patented technology, LentiFlash®, is to be rebranded as FlashRNA®. Why this […]